The Karolinska Institute in Stockholm will collaborate on drug development research with the Centre for Drug Research and Development (CDRD) in Canada.
The agreement, announced on 18 September, supports joint research projects, visits and training opportunities. The organisations are currently working to identify special areas of mutual interest.